KSpine Raises $2.5M for Spinal Implant to Treat Scoliosis

Minnesota medical device company KSpine raised $2.5 million that will fund clinical trials for the company’s spinal implant to treat scoliosis, according to a Medcity News report.

Advertisement

The KSpine implant involves fewer screws that traditional scoliosis treatments and only one rod. CEO Fred W. Kornahrens. Longhini, co-founder of Voyageur Medical, an early stage investor in medical device companies, said KSpine has raised $16 million since its start in 2008.

Related Articles on Medical Devices:
Novus Scientific Receives New U.S. Patent for Mesh Implant
Study: Automated Suturing Lowers Operating Time, Cost
How Technology Has Changed the Medical Industry

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.